These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 1355764)

  • 21. [A possible role of ultrasound-guided follicular aspiration in induction of ovulation in patients with polycystic ovaries].
    Katagiri C
    Nihon Sanka Fujinka Gakkai Zasshi; 1994 May; 46(5):409-15. PubMed ID: 8182300
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adrenal and ovarian steroid hormone responses to gonadotropin-releasing hormone agonist treatment in polycystic ovary syndrome.
    Gonzalez F; Hatala DA; Speroff L
    Am J Obstet Gynecol; 1991 Sep; 165(3):535-45. PubMed ID: 1832519
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disruption of the synchronous secretion of leptin, LH, and ovarian androgens in nonobese adolescents with the polycystic ovarian syndrome.
    Veldhuis JD; Pincus SM; Garcia-Rudaz MC; Ropelato MG; Escobar ME; Barontini M
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3772-8. PubMed ID: 11502810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of androgen blockade on granulosa cell estradiol production after follicle-stimulating hormone stimulation in women with polycystic ovary syndrome.
    Mehta RV; Malcom PJ; Chang RJ
    J Clin Endocrinol Metab; 2006 Sep; 91(9):3503-6. PubMed ID: 16804036
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mild adrenal and ovarian steroidogenic abnormalities in hirsute women without hyperandrogenemia: does idiopathic hirsutism exist?
    Escobar-Morreale HF; Serrano-Gotarredona J; García-Robles R; Sancho J; Varela C
    Metabolism; 1997 Aug; 46(8):902-7. PubMed ID: 9258272
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pituitary-ovarian response to the gonadotrophin-releasing hormone-agonist test in anovulatory patients with polycystic ovary syndrome: predictive role of ovarian stroma.
    Fulghesu AM; Angioni S; Belosi C; Apa R; Selvaggi L; Ciampelli M; Iuculano A; Melis GB; Lanzone A
    Clin Endocrinol (Oxf); 2006 Sep; 65(3):396-401. PubMed ID: 16918963
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative effects of cyproterone acetate or a long-acting LHRH agonist in polycystic ovarian disease.
    Schaison G; Couzinet B
    Horm Res; 1987; 28(2-4):169-74. PubMed ID: 2969860
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictive value of androgens and multivariate model for poor ovarian response.
    Guo J; Zhang Q; Li Y; Huang J; Wang W; Huang L; Zhao X; Yang D
    Reprod Biomed Online; 2014 Jun; 28(6):723-32. PubMed ID: 24745840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The hormonal response of patients with polycystic ovarian disease to subcutaneous low frequency pulsatile administration of luteinizing hormone-releasing hormone.
    Hurwitz A; Rosenn B; Palti Z; Ebstein B; Har-Nir R; Ron M
    Fertil Steril; 1986 Sep; 46(3):378-84. PubMed ID: 2943606
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of a long-acting gonadotropin-releasing hormone analog on the pituitary-ovarian-adrenal axis in women with severe hirsutism.
    Castelo-Branco C; Martínez de Osaba MJ; Martínez S; Fortuny A
    Metabolism; 1996 Jan; 45(1):24-7. PubMed ID: 8544772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative effects of cyproterone acetate or a long-acting gonadotropin-releasing hormone agonist in polycystic ovarian disease.
    Couzinet B; Le Strat N; Brailly S; Schaison G
    J Clin Endocrinol Metab; 1986 Oct; 63(4):1031-5. PubMed ID: 2943752
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of urinary human follicle-stimulating hormone and human menopausal gonadotropin for ovarian stimulation in polycystic ovarian syndrome.
    Larsen T; Larsen JF; Schiøler V; Bostofte E; Felding C
    Fertil Steril; 1990 Mar; 53(3):426-31. PubMed ID: 2106449
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Relationship between circulating androgens and ovarian hyperstimulation syndrome in anovulatory patients treated with hMG-hCG].
    Takahashi H; Inui Y; Mimura T; Kato H; Yamano S; Oono Y; Takeuchi S; Ezaki Y; Mori T
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 Dec; 34(12):2163-71. PubMed ID: 6818311
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ovulation induction in polycystic ovary syndrome with urinary follicle-stimulating hormone or human menopausal gonadotropin.
    Seibel MM; McArdle C; Smith D; Taymor ML
    Fertil Steril; 1985 May; 43(5):703-8. PubMed ID: 3922800
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Induction of follicle maturation with "pure" FSH in polycystic ovary syndrome].
    Birkhäuser MH; Huber PR; Neuenschwander E; Näpflin S
    Geburtshilfe Frauenheilkd; 1988 Apr; 48(4):220-7. PubMed ID: 3132413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined luteinizing hormone releasing hormone analogue and exogenous gonadotrophins for the treatment of infertility associated with polycystic ovaries.
    Homburg R; Eshel A; Kilborn J; Adams J; Jacobs HS
    Hum Reprod; 1990 Jan; 5(1):32-5. PubMed ID: 2108981
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Ovulation induction with pulsatile gonadotropin-releasing hormone and continuous human menopausal gonadotropin in polycystic ovarian disease].
    Kuroda G
    Nihon Naibunpi Gakkai Zasshi; 1987 Mar; 63(3):247-59. PubMed ID: 3111899
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hormonal effects of flutamide in young women with polycystic ovary syndrome.
    De Leo V; Lanzetta D; D'Antona D; la Marca A; Morgante G
    J Clin Endocrinol Metab; 1998 Jan; 83(1):99-102. PubMed ID: 9435423
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Ovarian stimulation for in vitro fertilization using LHRH agonists: comparison of plasma and intra-follicular hormone profiles using "short" and "long" protocols].
    Antoine JM; Firmin C; Alvarez S; Cornet D; Tibi C; Mandelbaum J; Plachot M; Salat-Baroux J
    J Gynecol Obstet Biol Reprod (Paris); 1990; 19(8):1035-40. PubMed ID: 2150525
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polycystic ovary syndrome: low-dose follicle stimulating hormone administration is a safe stimulation regimen even in previous hyper-responsive patients.
    Dale PO; Tanbo T; Haug E; Abyholm T
    Hum Reprod; 1992 Sep; 7(8):1085-9. PubMed ID: 1400931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.